US FDA approves Vanda's psychiatric drug
Feb 20 (Reuters) - The U.S. Food and Drug Administration has approved Vanda Pharmaceutical's VNDA.O drug for the treatment of two serious mental health conditions, the company said on Friday. (Reporting by Kunal Das and Sneha S K in Bengaluru; Editing by Maju Samuel) ((Kunal.Das2@thomsonreuters.com;))
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program